Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease
EARLY_PHASE1
52
about 4.9 years
55–85
1 site in TX
What this study is about
Researchers are testing whether supplementing glycine and N-acetylcysteine or alanine as a placebo affects brain metabolism, inflammation, and cognition in people with Alzheimer's disease. The trial will last for 1780 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Alanine
- 2.Glycine
- 3.N-acetylcysteine
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Therapeutic Nutrients/Minerals/Electrolytes (Biological Macromolecular Activity), glycine, acetylcysteine
oral (Oral Capsule)
Primary: Cognition
Secondary: Activities of daily living
Neurology